Norton Rose Add Leading Health & M&A Lawyer From Baker McKenzie in Sydney

Kate jefferson

Norton Rose Fulbright has added former Baker McKenzie lawyer Kate Jefferson to the Sydney team. A lawyer with over 20 years’ experience, she has been a top lawyer in the health and life sciences and with a wealth of Asian M&A deal experience behind her.

The firm’s media announcement is below –

Global law firm Norton Rose Fulbright welcomes Asia Pacific-focused partner Kate Jefferson, who joins the firm’s corporate team in Sydney. 

Kate is a senior transactional law partner with more than 20 years’ experience advising clients on high-profile, cross-border M&A and capital markets transactions in Australia and Asia Pacific.

Her experience includes private and public M&A, joint ventures, carve-outs, reorganisations, equity capital raisings and Australian Securities Exchange (ASX) governance requirements, with a particular focus on supporting clients in the life sciences and healthcare, technology and consumer markets industries.

Kate joins from global law firm Baker McKenzie where she was co-head of the Australian healthcare and life sciences group and a member of the firm’s Asia Pacific healthcare and life sciences steering committee. 

Her appointment follows the addition of new Norton Rose Fulbright partner Daniel Lin in May this year, working across Sydney and Tokyo and bringing a long history of advising clients on energy and infrastructure projects in Asia Pacific and a strong knowledge of Japan outbound M&A and financing matters. 

Norton Rose Fulbright Global Managing Partner; Managing Partner, Europe, Middle East and Asia Pacific Peter Scott commented:

“Kate’s history of advising clients on complex corporate and M&A transactions across Asia Pacific will strengthen our cross-border corporate offering and our broader Europe, Middle East and Asia Pacific (EMEAPAC) business. Her particular focus on the life sciences and healthcare industries dovetails with our strong global presence in these areas, as does her support of clients in technology and consumer markets.” 

Norton Rose Fulbright Australia Country Head Marshall Bromwich commented:

“I am delighted to welcome Kate to our firm. Kate’s extensive experience as a highly respected M&A and capital markets partner, and vast knowledge of many of our key industries, will greatly assist our clients in Australia and regionally. Together with our recent appointment of Daniel Lin, Kate further strengthens our Asia Pacific corporate team.”

Kate commented:

“The combination of Norton Rose Fulbright’s strong global platform, well-established Australian corporate practice and ambition to grow in Asia-Pacific was a major drawcard for me. I look forward to the opportunity to continue my support of clients across the life sciences and healthcare, technology and consumer markets industries, working alongside the firm’s corporate, regulatory and intellectual property partners.”

This announcement follows the appointment in Australia of partner Daniel Lin (energy and infrastructure, Sydney and Tokyo) in May; and Brad Robinson (banking and finance, Melbourne) in January 2026; and the 2025 appointments of partners Michael Gajic and Ashley Rose (public M&A and equity capital markets, Sydney) in June; and Kristina Mihalic (government, Canberra) in February. 

On 1 January 2026, Adele Gray (banking and finance, Melbourne), Fridoun Chee (corporate, M&A and securities, Sydney), Jiadi Liang and Veronica Seeto (government, Canberra), Daniel Posker (intellectual property, Sydney), and Jeremy Moller (risk advisory, Sydney) were promoted to partner in Australia.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top